Edition:
United Kingdom

Galmed Pharmaceuticals Ltd (GLMD.OQ)

GLMD.OQ on NASDAQ Stock Exchange Capital Market

8.55USD
4:31pm GMT
Change (% chg)

$-0.11 (-1.27%)
Prev Close
$8.66
Open
$8.52
Day's High
$8.64
Day's Low
$8.36
Volume
3,531
Avg. Vol
28,746
52-wk High
$27.06
52-wk Low
$3.61

Chart for

About

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product candidate,... (more)

Overall

Beta: 2.60
Market Cap(Mil.): $117.83
Shares Outstanding(Mil.): 12.64
Dividend: --
Yield (%): --

Financials

  GLMD.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.22 -- --
ROI: -137.95 9.01 14.96
ROE: -140.43 10.15 16.52

Earnings vs. Estimates